Patents by Inventor Felix LANSING

Felix LANSING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11845954
    Abstract: The invention provides methods for specifically altering the DNA sequence in a genome, in particular for genome editing by deleting or replacing a sequence of interest. Advantageously, the invention uses two non-identical sequences naturally occurring in a genome as target sites two which DNA-recombining enzymes are generated. The invention is in particular useful for medicine, in particular to repair a mutation in a genome or to delete predefined genetic material from cells or tissue and to cure diseases. An advantage of the invention is that it allows precise site directed altering of DNA without engaging host DNA repair pathways and thereby works without inducing random insertions and deletions (indels).
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: December 19, 2023
    Assignee: TECHNISCHE UNIVERSITÄT DRESDEN
    Inventors: Frank Buchholz, Martin Schneider, Felix Lansing
  • Publication number: 20230235364
    Abstract: The invention provides methods and means for specifically altering the DNA sequence in a genome, in particular for genome editing by deleting or replacing a sequence of interest. Advantageously, the invention uses two non-identical sequences naturally occurring in a genome as target sites two which DNA-recombining enzymes are generated. The invention is in particular useful for medicine, in particular to repair a mutation in a genome or to delete predefined genetic material from cells or tissue and to cure diseases. An advantage of the invention is that it allows precise site directed altering of DNA without engaging host DNA repair pathways and thereby works without inducing random insertions and deletions (in-dels).
    Type: Application
    Filed: October 12, 2022
    Publication date: July 27, 2023
    Inventors: Frank BUCHHOLZ, Martin SCHNEIDER, Felix LANSING
  • Publication number: 20230183713
    Abstract: The invention relates to the field of genome editing and provides a method of generating DNA recombinases or provides DNA recombinases, which efficiently and specifically recombine genomic target sequences as obligate DNA recombinase enzymes.
    Type: Application
    Filed: November 15, 2022
    Publication date: June 15, 2023
    Inventors: Jenna HOERSTEN, Felix LANSING, Frank BUCHHOLZ
  • Publication number: 20210147878
    Abstract: The invention provides methods and means for specifically altering the DNA sequence in a genome, in particular for genome editing by deleting or replacing a sequence of interest. Advantageously, the invention uses two non-identical sequences naturally occurring in a genome as target sites two which DNA-recombining enzymes are generated. The invention is in particular useful for medicine, in particular to repair a mutation in a genome or to delete predefined genetic material from cells or tissue and to cure diseases. An advantage of the invention is that it allows precise site directed altering of DNA without engaging host DNA repair pathways and thereby works without inducing random insertions and deletions (indels).
    Type: Application
    Filed: June 14, 2018
    Publication date: May 20, 2021
    Applicant: TECHNISCHE UNIVERSITÄT DRESDEN
    Inventors: Frank BUCHHOLZ, Martin SCHNEIDER, Felix LANSING